Found 938 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
This study will assess the ex vivo use of established and in-house near-infrared fluorophores for imaging brain tumors. Fluorophores will be topically applied to freshly excised tumor specimens for imaging on the surgical back table. Participants are patients undergoing surgery for CNS tumors who consent to use of their specimens. …
This study investigates an investigational medication designed to treat patients with advanced or metastatic solid tumors. The purpose of this study is to discover if the investigational medication can slow or stop cancer growth and to learn about its safety. The study will focus on various types of advanced cancers, …
This study aims to determine the long-term effects of CTL019 on patients who were enrolled in UPCC 13413: "Phase IIa Study of Redirected Autologous T-Cells Engineered to Contain Anti-CD 19 Attached to TCR and 4- BB Signaling Domains in Patients with Chemotherapy Relapsed of Refractory CD 19+ Lymphomas". It also …
This study investigates treatment combinations for ovarian cancer, a serious disease affecting many women worldwide. The purpose of this study is to assess the safety and effectiveness of different combinations of an investigational medication with other treatments in individuals with ovarian cancer. Participants in this study must have a specific …
This study investigates treatment options for patients with non-small cell lung cancer (NSCLC) that have mutations in the epidermal growth factor receptor (EGFR) gene. Patients in this study have experienced disease progression despite previous treatment with EGFR tyrosine kinase inhibitors, which are medications that block signals promoting cancer cell growth.Participants …
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an add-on with statin therapy and on the market to lower LDL-C in high-risk populations.
A single-dose, open-label, dose-escalation Phase 1b study in patients scheduled to undergo minimally invasive surgery (MIS) for known or suspected lung cancer via thoracoscopy (i.e., VATS). Single dose IV administration of Pemofolacianine for Injection, either on the day before surgery or on the day of surgery, with 2 different doses …
This study investigates an investigational therapy for treating HIV-associated aggressive B-cell non-Hodgkin lymphoma that has either returned or not responded to previous treatments. The purpose is to evaluate the safety and feasibility of using genetically modified T cells, known as CAR-T therapy, which are designed to target a specific protein …
This study investigates the safety, tolerability, and effectiveness of an investigational medication combined with pembrolizumab in individuals with advanced solid tumors. The purpose of this study is to identify the best doses for future research and to understand how the body processes and responds to the treatment.Participants will receive the …
This study investigates the use of trained detection dogs and artificial intelligence (AI) to identify breast cancer from a person's breath. The purpose of this study is to understand if this method can accurately detect breast cancer in women who are scheduled for routine screening, such as mammograms, ultrasounds, or …
Please choose between Voice or SMS based delivery of verification code
or